A Stellar Start to 2021 for Lucid Group
March 16, 2021 | Jobs, Lucid, Medical Communications, appointments, healthcare communications, promotions
It’s been a stellar start to 2021 for Lucid Group, which has welcomed 38 new starters into the company since the beginning of the year. These include 15 Client Services colleagues, 14 medical writers, 5 scientific directors, 3 new people supporting our Finance and Legal central services teams and 1 new business leader.
Aside from the many new talent acquisitions made, Lucid has also been busy celebrating the successes from within its own teams with a total of 24 promotions. This included Sally Stringer being promoted to Managing Partner of the HealthCare21 team.
Sally commented, “I am thrilled to be taking the helm, to ensure the HealthCare21 team continues to inspire and invigorate our clients, maintain our values and drive positive transformation within healthcare.”
Another two of these promotions were into new, exciting roles: Tanya Goodyear was appointed Director of Innovation and Technology and Cheryl Harrison Doyle was promoted to Global Asset Strategy Director. Before moving into her new role, Tanya was Managing Partner for Lucid’s medcomms team, Origins, and Cheryl previously held the position of Client Partnership Director.
Both of these new roles demonstrate Lucid’s ambition to build a global, industry-leading multi-capability healthcare communications company. It’s an extremely exciting time to be joining the organisation as it builds scale and develops new services for its clients. For example, as Global Asset Strategy Director, Cheryl will lead the identification and integration of key capabilities and programmes that go beyond medcomms to support clients in meeting their strategic priorities and improve health outcomes.
Cheryl commented, “I have been with Lucid Group now for more than 11 years and I am delighted and honoured to have the opportunity of pioneering a new capability within the organisation. This role is fundamental to supporting our continued success, both within and beyond medical communications. I look forward to the challenge and creating new opportunities that support our clients to meet their strategic goals.”
As a purpose-driven company, everything we do is underpinned by our passion and desire to transform the lives of those we touch, including our teams, clients, partners, our communities and for patients.
We are entering a new and exciting phase at Lucid Group. Our partnership with Intermediate Capital Group (ICG) will allow us to transform more lives than ever before. So, if you’re looking to transform yours, join us – we’re hiring!
Contact our talent acquisition managers Daniel Newbury or Lucinda Fowkes to discuss the great career opportunities we have to offer.
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
A summer meeting full of magical moments
In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...
Sir Henry presents Queen’s Award for Enterprise to Lucid Group
On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...
Lucid Group’s winning formula is recognised at Communiqué 2017
Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...
Lucid Partners grows its medical writing team
The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...
Using insights to effect behaviour change
The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...
All five of Lucid’s entries reach the shortlist for Communiqué 2017
Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group Excellence in Communications via...
Your career starts here
When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...
Are you suffering from templatitis?
At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...
It’s time to shine for Lucid’s rare disease team
No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...
Focus on Rare Diseases
As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.